These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inflammatory Bowel Diseases: The Role of Gut Microbiota. De Musis C, Granata L, Dallio M, Miranda A, Gravina AG, Romano M. Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042 [Abstract] [Full Text] [Related]
25. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood. Eindor-Abarbanel A, Healey GR, Jacobson K. Int J Mol Sci; 2021 Nov 19; 22(22):. PubMed ID: 34830388 [Abstract] [Full Text] [Related]
28. Nutritional Support and Probiotics as a Potential Treatment of IBD. Tarasiuk A, Eibl G. Curr Drug Targets; 2020 Nov 19; 21(14):1417-1427. PubMed ID: 32364071 [Abstract] [Full Text] [Related]
29. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues. Lee M, Chang EB. Gastroenterology; 2021 Jan 19; 160(2):524-537. PubMed ID: 33253681 [Abstract] [Full Text] [Related]
30. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease. Schulberg J, De Cruz P. Intern Med J; 2016 Mar 19; 46(3):266-73. PubMed ID: 26968595 [Abstract] [Full Text] [Related]
31. The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Kanauchi O, Mitsuyama K, Andoh A. Curr Pharm Des; 2009 Mar 19; 15(18):2074-86. PubMed ID: 19519445 [Abstract] [Full Text] [Related]
32. Inflammatory bowel disease, gut bacteria and probiotic therapy. Reiff C, Kelly D. Int J Med Microbiol; 2010 Jan 19; 300(1):25-33. PubMed ID: 19800289 [Abstract] [Full Text] [Related]
33. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C, Whelan K, Lindsay JO. Proc Nutr Soc; 2007 Aug 19; 66(3):307-15. PubMed ID: 17637082 [Abstract] [Full Text] [Related]
34. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Aleksandrova K, Romero-Mosquera B, Hernandez V. Nutrients; 2017 Aug 30; 9(9):. PubMed ID: 28867793 [Abstract] [Full Text] [Related]
35. The gut microbiota and inflammatory bowel disease. Matsuoka K, Kanai T. Semin Immunopathol; 2015 Jan 30; 37(1):47-55. PubMed ID: 25420450 [Abstract] [Full Text] [Related]
36. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Geier MS, Butler RN, Howarth GS. Int J Food Microbiol; 2007 Apr 01; 115(1):1-11. PubMed ID: 17137666 [Abstract] [Full Text] [Related]
37. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. World J Gastroenterol; 2014 Oct 28; 20(40):14805-20. PubMed ID: 25356041 [Abstract] [Full Text] [Related]
38. Probiotics, Prebiotics, Fecal Microbiota Transplantation, and Dietary Patterns in Inflammatory Bowel Disease. Noguera-Fernández N, Candela-González J, Orenes-Piñero E. Mol Nutr Food Res; 2024 Sep 28; 68(18):e2400429. PubMed ID: 39194379 [Abstract] [Full Text] [Related]
39. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD. Martyniak A, Medyńska-Przęczek A, Wędrychowicz A, Skoczeń S, Tomasik PJ. Biomolecules; 2021 Dec 18; 11(12):. PubMed ID: 34944546 [Abstract] [Full Text] [Related]
40. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A. Biomed Res Int; 2013 Dec 18; 2013():435268. PubMed ID: 23991417 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]